Physician profile
Ryan A Strain
NPI 1538397690
$14,327.11
in general payments reported to CMS, 2019-2025
13 companies · $41.37 in 2025
The $41.37 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $65.51 · 2021: $129 · 2022: $277 · 2023: $13K · 2024: $643 · 2025: $41.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,113 · Travel and Lodging: $3,487 · Food and Beverage: $1,238 · Gift: $16.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,112.84 |
| Travel and Lodging | $3,487.14 |
| Food and Beverage | $1,238.02 |
| Gift | $16.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,117.10 | 2023-2025 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $535.96 | 2022-2024 | Signia |
| Ethicon US, LLC | $359.49 | 2020-2025 | Echelon Flex, Echelon Endopath, Stratafix |
| Baxter Healthcare | $67.90 | 2021-2024 | Tisseel |
| Innocoll Pharmaceuticals Limited | $57.86 | 2021-2022 | |
| Novo Nordisk INC | $52.69 | 2024 | Wegovy |
| Conmed Corporation | $25.77 | 2024 | Airseal |
| Phathom Pharmaceuticals, INC. | $21.64 | 2024 | Voquezna |
| Paratek Pharmaceuticals, INC. | $21.52 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $20.40 | 2023 | Imcivree |
| Allergan, INC. | $16.65 | 2021 | |
| Endo Pharmaceuticals INC. | $15.92 | 2020 | |
| Teleflex LLC | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Strain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.